Physiological Insulin Resensitization

Patients with diabetes often face complications such as foot ulcers, neuropathy, and slow wound healing. PIR therapy aims to provide an alternative treatment option that can address these complications and improve overall health by targeting the root cause of diabetes, which is insulin resistance.

Mechanism of Action

Physiologic Insulin Resensitization therapy works by reducing insulin resistance, the primary cause of type 2 diabetes and other metabolic disorders. It achieves this by improving insulin sensitivity at the insulin receptor level.

Our Services

Reduction in medication usage/dosage:

Both type 1 and type 2 diabetes patients may experience a reduction in the need for diabetes medications.

HbA1c reduction:

Physiologic Insulin Resensitization therapy can lead to improvements in glycated hemoglobin (HbA1c) levels, indicating better blood sugar control.

Diabetic peripheral neuropathy:

Neuropathic symptoms may improve with Physiologic Insulin Resensitization therapy

Chronic kidney disease:

Some patients with diabetes and related kidney disease may experience improvements in their condition.

Improved wound healing:

Physiologic Insulin Resensitization therapy can enhance wound healing, which is particularly crucial for individuals with diabetic foot ulcers.

Retinopathy improvements:

Physiologic Insulin Resensitization therapy may have positive effects on diabetic retinopathy.

  • Both type 1 and type 2 diabetes patients may experience a reduction in the need for diabetes medications.

  • Physiologic Insulin Resensitization therapy can lead to improvements in glycated hemoglobin (HbA1c) levels, indicating better blood sugar control.

  • Neuropathic symptoms may improve with Physiologic Insulin Resensitization therapy

  • Some patients with diabetes and related kidney disease may experience improvements in their condition.

  • Physiologic Insulin Resensitization therapy can enhance wound healing, which is particularly crucial for individuals with diabetic foot ulcers.

  • Physiologic Insulin Resensitization therapy may have positive effects on diabetic retinopathy.

  • Both type 1 and type 2 diabetes patients may experience a reduction in the need for diabetes medications.

  • Physiologic Insulin Resensitization therapy can lead to improvements in glycated hemoglobin (HbA1c) levels, indicating better blood sugar control.

  • Neuropathic symptoms may improve with Physiologic Insulin Resensitization therapy

  • Some patients with diabetes and related kidney disease may experience improvements in their condition.

  • Physiologic Insulin Resensitization therapy can enhance wound healing, which is particularly crucial for individuals with diabetic foot ulcers.

  • Physiologic Insulin Resensitization therapy may have positive effects on diabetic retinopathy.